Related Experiment Video
Updated: Aug 25, 2025

Biomolecular Detection employing the Interferometric Reflectance Imaging Sensor IRIS
Published on: May 3, 2011
ATR-FTIR Biosensors for Antibody Detection and Analysis
Olivier Suys1, Allison Derenne1, Erik Goormaghtigh1
1Center for Structural Biology and Bioinformatics, Laboratory for the Structure and Function of Biological Membranes, Campus Plaine CP206/02, Université Libre de Bruxelles, B1050 Brussels, Belgium.
A new biosensor accurately detects immunoglobulins during biopharmaceutical production. This tool ensures drug product quality by monitoring critical quality attributes like structure and aggregation.
Area of Science:
- Pharmaceutical Science
- Biotechnology
- Analytical Chemistry
Background:
- Quality control is crucial for pharmaceutical products, especially complex biomolecules like therapeutic proteins.
- Bioprocess variations can significantly alter protein structure and impact drug quality.
- Monitoring critical quality attributes (CQAs) during production is essential.
Purpose of the Study:
- To develop a cost-effective and rapid biosensor for detecting immunoglobulins during biopharmaceutical production.
- To enable real-time monitoring of CQAs such as high-order structure and aggregation.
- To improve the quality control of biotherapeutic manufacturing.
Main Methods:
- Optimized reproducible grafting of 11-mercaptoundecanoic acid onto a germanium crystal.
- Developed an attenuated total reflection-Fourier transform infrared (ATR-FTIR) spectroscopy-based biosensor.
- Functionalized the germanium crystal surface with immunoglobulin-binding proteins for specific capture.
Main Results:
- Achieved highly reproducible grafting of the functional coating.
- Demonstrated the biosensor's ability to specifically bind immunoglobulins from complex media.
- Validated the biosensor as a tool for monitoring biotherapeutic production and assessing CQAs.
Conclusions:
- The developed biosensor is an easy-to-use, cost-effective, and time-saving tool for immunoglobulin detection.
- This biosensor facilitates the monitoring of biotherapeutic production and the assessment of critical quality attributes.
- It offers a powerful method for ensuring the safety, efficiency, and consistency of drug products.
More Related Videos
15:27Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms
Published on: April 17, 2017
08:26Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
Published on: June 14, 2018